Aurora Cannabis Inc
Gauging the Bullish-Bearish Sentiment on Aphria
The short interest position on a stock is one quick way to gauge the bullish and bearish sentiment on a stock.
Investors: An Important Trend before Investing in Cannabis
As of February 22, the median EV-to-EBITDA valuation multiple for the nine stocks was 25.1x. On February 8, the median multiple was 22.1x.
Why Product Landscape Design Matters for Cannabis Stocks
The popularity of various cannabis consumption methods could guide the product landscape design for cannabis companies.
SMG’s Margin Expectations Could Be Concerning
The Scotts Miracle-Gro Company (SMG) continues to face margin headwinds in the lawn and garden segment.
MedMen’s Territory Expansion: The Recent Agreements
MedMen (MMNFF) has entered into agreements with different companies to expand its footprint. We outline a few of the recent agreements below.
How Last Week Was for the Cannabis Sector
Last week (ended April 27), cannabis-sector ETFs ended in negative territory.
Tilray’s Q2 2018 Results and Its Strategic Focus
Tilray’s (TLRY) average selling prices and sales volume improved YoY in the second quarter. The company sold 1,514 kilograms during the quarter.
More Valuations for the Cannabis Sector in October
The median forward EV-to-EBITDA multiple for our nine cannabis companies on October 8 was 43.2x. That was 30% lower than September.
Do CGC, ACB, TLRY, and APHA Look Cheap?
With the exception of Aphria, Tilray, Canopy Growth, and Aurora Cannabis were trading at a premium to the peer median EV-to-EBITDA multiple.
Cronos Group Invests in the Future
Through Cronos Group’s partnership with Ginko Bioworks, the company aims to produce cannabis through fermentation.
ACB, APHA, CTST, and HEXO Fall on March 20
The Horizons Marijuana Life Sciences ETF (HMMJ) had fallen by about 1.2% as of noon on March 20, while the ETFMG Alternative Harvest ETF (MJ) had declined by nearly 0.8%.
Tobacco Companies and Their Newfound Interest in Cannabis
On October 10, Reuters reported that tobacco giant Altria is in discussions with Aphria (APHQF) about acquiring a stake in the company.
Innovative Industrial Properties Declared Q1 Dividend
On March 12, Innovative Industrial Properties’ board declared its first-quarter dividend. The company declared a dividend of $0.45 per share.
Aurora Cannabis: Analysts’ Projections
Analysts expect Aurora Cannabis to report a gross income of 177 million Canadian dollars in 2019 and 508 million Canadian dollars in 2020.
Checking On Canopy Growth and Its Peers
Canopy Growth is one of the strongest players in the cannabis industry with a market cap of ~24 billion Canadian dollars.
Does Cronos Group Look Expensive Compared to Its Peers?
Cronos Group (CRON) has been on a declining trend for a while. The stock rose to a peak of ~30 Canadian dollars in February.
Take a Look at Valuations before Jumping into Cannabis Stocks
Cannabis stocks have soared in recent weeks in anticipation of October 17, the date when recreational cannabis sales are slated to begin in Canada.
Marijuana Movement: Why Do Celebrities Support It?
Marijuana is gaining more and more attention. What’s caught the most attention is that many celebrities are joining the growing support movement.
Will IIPR Still Be an Investor Favorite Post Q3 Earnings?
Innovative Industrial Properties (IIPR) is set to report its third-quarter results tomorrow. IIPR stock, up 67.2% year-to-date, has been investor favorite.
Why Aurora Cannabis Calls Itself a ‘Medical Company at Heart’
Aurora Cannabis (ACB) reported its Q2 earnings yesterday, which gave us a glimpse of recreational cannabis sales activity and what to expect from peers’ (MJ) upcoming earnings.
What Does President Trump Think about Marijuana?
President Trump hasn’t directly supported or opposed marijuana. In the past, he said that marijuana makes people “lose IQ points.”
Canaccord Genuity Raises Price Target for Canopy Growth
On February 18, Canopy Growth (WEED) received a price target upgrade from Canaccord Genuity.
Top Developments in the Cannabis Industry’s Early Years
In the second half of 2018, the cannabis industry remained busy. As the cannabis sector experienced a boom, there was a lot of excitement among investors.
Why Vaping May Not Be a Gold Mine for Cannabis Players
In recent years, vaping devices or e-cigarettes have been considered safer than tobacco cigarettes. However, the rise in vaping is now a matter of concern.
Aurora Cannabis’s Revenue: Here’s What Analysts Expect
Aurora Cannabis is set to release its fiscal 2020 first-quarter earnings results on November 11. Let’s see what analysts expect for its upcoming quarter.
Aurora Cannabis’s Price Target Cut by 30%
Aurora Cannabis (ACB) stock is currently down 29.23% on the NYSE on a YTD (year-to-date) basis. The company has lost 14.81% of its value since October 1.
Marijuana Policy: Can California Shape It for the US?
Marijuana reform has always been important in California, which became the first state to legalize medical marijuana in 1996.
Scotts Miracle-Gro: Analysts’ Recommendations in February
For Scotts Miracle-Gro, one analyst recommended a “strong buy,” three recommended a “buy,” and three recommended a “hold.”
Marijuana to Treat New Conditions in Minnesota
In August 2020, chronic pain and age-related macular degeneration would be eligible for treatment under Minnesota’s medical marijuana program.
Cannabis Legalization: Four Governors Met in New York
The Day reported that New York, New Jersey, Connecticut, and Pennsylvania’s governors met and agreed on basic guidelines for legalizing marijuana.
TLRY, CGC, CRON, and CTST Continue to Slide on April 11
The first half of April 11 proved to be yet another dampener for cannabis investors’ expectations.
Cannabis Investment: How to Buy ACB, CGC, and Other Stocks
Cannabis is a hot sector that’s constantly evolving. Right now, how to buy cannabis stocks is a question that’s likely on many investors’ minds.
Biggest Gainers in the Cannabis Sector Last Week
In the week ending April 5, the overall cannabis sector ended in the positive territory. HMMJ rose ~0.93% last week.
Tilray’s November Price Target and Recommendation Update
Tilray (TLRY), which reported its earnings on November 13, missed both top-line and bottom-line consensus estimates.
Canopy Growth Receives Target Price Upgrades
Cormark Securities raised its target price for Canopy Growth to 40 Canadian dollars from 33 Canadian dollars, which represents an increase of almost 21%.
Cannabis in Mexico: Legalization Bill Is Ready for Voting!
Cannabis legalization is approaching the deadline in Mexico. According to the Supreme Court, the deadline for marijuana legalization is Wednesday.
Mexico Will Attempt to Legalize Marijuana in 2020
Mexico is ready with a revised proposal to legalize marijuana this year. The Supreme Court gave lawmakers until April 30 to submit the new proposal.
Tilray Invests in ROSE LifeScience
On December 14, Tilray (TLRY) announced that it’s investing in ROSE LifeScience—a cannabis producer in Quebec.
Comparing Cannabis Stocks’ EV-to-EBITDA Multiples
In this part, we’ll compare how these producers’ multiples compare with each other.
Canopy Growth Looks for CEO, Linton Gets a New Role
Canopy Growth took the market by surprise and let CEO Bruce Linton go. After leaving Canopy Growth, Linton joined three companies in an advisory role.
Revisiting Valuation Multiples for Cannabis Companies
Recreational cannabis is close to being legalized in Canada, and producers are running at full bore to capture a piece of the market.
HEXO: Analysts’ Target Price and Ratings
CIBC downgraded HEXO to “neutral” from “outperform” and reduced the target price to 8.5 Canadian dollars from 9.5 Canadian dollars.
Cannabis Sector Closes Positively in the Week Ended April 13
Last week (ended April 13), overall market sentiment was positive, with the S&P 500 rising 2% and the TSX 30 gaining 44 basis points.
The Cannabis Sector: Mergers, Acquisitions, and Price Upgrades
The cannabis sector remains hot for mergers and acquisitions as companies rush to capture a piece of the recreational cannabis market.
Canopy Growth Stock Rises, Oppenheimer Initiates Coverage
Oppenheimer analyst Rupesh Parikh initiated coverage on Canopy Growth stock. The analyst gave a “perform” rating with no target price.
What Do Analysts Recommend for Canopy Growth?
On December 16, Canopy Growth was trading at 26.79 Canadian dollars, implying a rise of 9.6% since its fiscal 2020 second-quarter earnings release.
Can Canopy Beat Q2 Estimates and Boost the Sector?
This week is important for the cannabis sector, as Canopy Growth and Aurora Cannabis are both set to report their earnings results on November 14.
Cronos Group Joins Altria to Bet on Cannabidiol Market
Cannabis company Cronos Group has expanded its presence in the US cannabidiol market through a tie-up with tobacco company Altria Group.
Canopy Growth: Key Takeaways from Its Investor Call
Yesterday, Canopy Growth CFO Mike Lee seemed optimistic when he presented at the Barclays 2019 Global Consumer Staples Conference.
Where Canadians Would Prefer to Buy Recreational Marijuana
In the previous part of this series, we briefly discussed how the different active components of the cannabis plant make it a more complex product than tobacco and alcohol.
Marijuana Vape Products Expected in Alberta Stores
AGLC will allow retail stores in Alberta to sell marijuana vape products. Consumers will likely be able to purchase cannabis vape products in the next two weeks.
Canopy Growth Is Optimistic about Cannabis Market
Recreational cannabis sales began in Canada on October 17. Canada is only the second country after Uruguay to legalize cannabis.
Why Canopy Growth Isn’t Happy with Apple
Apple removed 181 vaping-related apps due to the vape crisis in the US. Canopy Growth is not happy with Apple’s move. Let’s see why.
Aurora Cannabis: What to Expect from Its Q4 Results
Aurora Cannabis should report its fourth-quarter earnings results on Thursday. So far, September has been positive. As of Monday, the stock has gained 8.7%.
South Dakota Plans for Marijuana Legalization amid COVID-19
Marijuana is illegal in South Dakota. However, the state decided to make both recreational and medical marijuana legal this year.
Marijuana Legalization Continues: Wisconsin Steps Up!
Marijuana laws are pretty strict in Wisconsin. Although cannabis is spreading its roots across US states, it’s still illegal at the federal level. President Trump and his administration want states to decide. Florida, New York, and Minnesota are all gearing up to legalize adult-use cannabis. Now, Wisconsin is pushing to legalize medical marijuana. Let’s see […]
Is Aphria a Good Cannabis Pick for 2020?
Aphria has successfully strengthened its position not only in Canada but also in international markets. The company reported impressive second-quarter results.
Will MedMen Deliver Any Good News in Its Q2 Earnings?
MedMen will report its earnings results for the second quarter of fiscal 2020 on Wednesday. Analysts expect 67.6% YoY revenue growth.
Cannabis 2.0: Aphria Gets Ready for Edibles Market
Cannabis 2.0 legalization will take place in Canada this month. Aphria plans to expand its consumer base in the vape and concentrates business.
Big News: Cannabis Edibles in Alberta Stores
Many people expected the Cannabis 2.0 products, including cannabis edibles, to hit the markets by mid-December 2019. However, the products got delayed.
Elizabeth Warren Unveils Plan for Marijuana Legalization
According to Warren’s new marijuana plan, the federal legalization process would start within 100 days of her taking office.
Aurora Cannabis Inches Closer to Acquiring ICC Labs
A special meeting will be held on November 6 to urge shareholders to approve the arrangement between Aurora Cannabis and ICC Labs.
Medical Marijuana Is Booming in OK, Struggles in OH
Medical marijuana is a hit in Ohio since it allowed it in 2016. Recreational cannabis is still not allowed. Notably, data has shown that Ohio’s medical cannabis industry is booming since it started in 2019. However, the medical cannabis industry is facing some setbacks as well. So, let’s take a look at it. Ohio and […]
Marijuana Industry: Opportunities in California amid COVID-19
Marijuana is an old but growing market in California. Notably, California became the first state to legalize medical marijuana in 1996.
Medical Cannabis in Brazil Is Coming
According to a Reuters report on December 3, Brazil is ready to approve medical cannabis products. Currently, cannabis is illegal in Brazil.
Cannabis Sector 2019 Review and 2020 Outlook
Canada legalized cannabis in October 2018, so investors expected 2019 to drive marijuana sales. However, the fate of the industry took a sharp turn.
How Cannabis Stocks Fared Last Week
Tilray was the top performer in the cannabis sector last week with a rise of 49% as a result of better-than-expected second-quarter earnings and guidance.
Is New Jersey Closer to Legalizing Recreational Cannabis?
If New Jersey passes the bill to legalize recreational cannabis, it will become the 11th state to legalize recreational cannabis in the United States.
Marijuana: Will Trump Have an Edge over Biden?
With Biden strongly opposing full-scale legalization, President Trump could turn around things. President Trump might support medical marijuana legalization.
Aurora Cannabis: Analysts’ Target Price after Its Earnings
Aurora Cannabis (ACB) reported its fourth-quarter results on September 11. The results disappointed analysts and investors.
CBD: Japan Welcomes NBEV, Stock Pops
Today, New Age Beverages Corporation (NBEV) announced that it would launch its CBD (cannabidiol) based products. Share prices jumped by 14.96% to $3.20.
Marijuana Legalization: O’Rourke Blazes His 2020 Campaign
Democratic presidential candidate Beto O’Rourke is known for voicing his opinion on federal marijuana legalization. He supports marijuana legalization.
Aurora Cannabis: Does Investment in Liquor Stores Fit Framework?
With the opportunity for private players to run cannabis stores in British Columbia and Alberta, the partnership of Aurora Cannabis and Liquor Stores NA could come at an opportune time.
Marijuana Legalization: South Dakota Does What Trump Said!
Marijuana legalization is ramping up. Now, South Dakota is taking President Trump’s advice. The state is kicking off a petition to legalize cannabis.
Scotts Miracle-Gro Explores Opportunities in Cannabis Market
SMG’s partnership with the Flowr Corporation could give it an opportunity to pursue options to enter the cannabis cultivation business.
Aphria: Why Jefferies Recommends a ‘Buy’
Aphria (APHA) reported its results for the first quarter of fiscal 2020 on October 15. Since then, the stock has fallen 7%.
Canopy Gets Estimates Revised by Analysts for 2020
Canopy Growth (CGC) (WEED) missed analysts’ estimates this year. Analysts had huge expectations from CGC after Canada allowed cannabis in 2018.
Tilray: Are Analysts Optimistic about Its Stock?
After Tilray’s second-quarter earnings, Benchmark reduced its target price to $80 from $120. Cowen and Company reduced the target price to $60 from $150.
Cannabis Roundup: HEXO, WEED, ACB, and CTST
The broader US markets were relatively flat today. Weakness in the cannabis sector continued, with the ETFMG Alternative Harvest ETF down 0.4%.
Cannabis in Kansas: Residents Are Taking Action
Currently, 33 states and Washington, D.C., have legalized medical cannabis, but it’s illegal in Kansas. Even having a small amount is considered a crime.
Why Aurora Cannabis Stock and Peers Are Struggling
Aurora Cannabis (ACB) had a hard time this year. ACB stock had been investors’ favorite in 2018. The stock started off 2019 on a good note
Why Alcaliber Makes Sense for Canopy Growth
On March 6, Bloomberg Markets reported that Canopy Growth (WEED) put in a bid for privately held Spanish company Alcaliber.
Canopy Growth: Why PI Financial Suggests a ‘Sell’
Canopy Growth dragged its stock down after its unimpressive end to fiscal 2020. The company missed the revenue estimates by a huge margin.
Will Santa Claus Rally Boost Cannabis Stocks?
On December 26, a Santa Claus rally seems to be in full swing. This effect pushed the S&P 500 (SPX) and Nasdaq Composite Index (COMP) to record highs.
What to Expect from IIPR’s Earnings for Q3
Innovative Industrial Properties (IIPR) is scheduled to release its Q3 earnings results on November 6. Find out what cannabis investors can expect.
Joe Biden Won’t Legalize Cannabis—Why?
Although Joe Biden supported medical cannabis in his previous presidential campaigns, he has always opposed full-scale legalization.
Canada’s Cannabis Act C-45 Makes Progress in the Senate
On May 28, Bill C-45, Canada’s recreational cannabis legalization bill, saw further progress in the Senate.
Marijuana in Texas: Five Things You Should Know
Marijuana laws are pretty strict in Texas, but could this change? Here are five things you need to know about the state’s relationship with marijuana.
Price Target Update for Canopy Growth in January
Canopy Growth (WEED) (CGC) has continued to deepen its roots in the United States with a recent announcement that could be a game changer.
Why Canopy Growth Is Partnering with Drake
The Canadian Press reported that Canopy Growth is partnering with rapper Drake to launch a new cannabis venture, the More Life Growth Company.
How Tilray Is Advancing in International Markets
In its earnings call, Tilray (TLRY) stated that its Canadian entity will serve as a production hub to meet global cannabis demand.
Medical Cannabis: A Hot Topic at Events Across the World
These days, experts are discussing the pros and cons of medical cannabis at multiple conferences and summits around the world.
Cannabis Sector: A Week in Review for Sept 20
Last week, the overall cannabis sector remained subdued. Sector ETFs, such as the Horizons Marijuana Life Sciences ETF (HMMJ), closed about 8.15% lower.
Why Marijuana Revenues in Colorado Keep Rising
Colorado reported $1.16 billion in marijuana sales in the first eight months of 2019. In 2018, the state reported marijuana sales of $1.54 billion.
Key Takeaways on the SAFE Banking Act Hearing
On Tuesday, the US Senate held a hearing on the SAFE (Secure and Fair Enforcement) Banking Act. On March 26, the House Committee passed the act. The act will need to pass the Senate before it is sent to the US president. If passed, the act would greatly help US cannabis businesses. What is the […]
Cannabis Sector Update for the Week Ended May 4
Last week was broadly positive for the cannabis sector. The ETF Horizons Marijuana Life Sciences (HMMJ) rose 2.4%.
Which Cannabis Stocks Have Lost More than 40% in 2019?
The cannabis industry has been on a rollercoaster ride this year. CannTrust, Tilray, and KushCo stocks have fallen more than 40% in 2019.
Cannabis Legalization: Is It Time for the US to Act?
Cannabis legalization has America’s attention. A Gallup survey has shown that two-thirds of Americans want cannabis legalized now.
Cannabis 2.0 Legalization: Canada Is Ready
Federally, cannabis legalization saw daylight in Canada in 2018. The Cannabis Act legalized recreational marijuana in October 2018. Now, the country is all set for the second wave of legalization, Cannabis 2.0, which includes cannabis edibles, cannabis-infused beverages, extracts, and various other products. Let’s dig into this more. Canada’s second wave of legalization Next month, […]
Aphria: Last Week Was Eventful
On December 27, Aphria came in play after Green Growth Brands announced its bid to take over the company for 11 Canadian dollars per share.